Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Mar;66(3):370-5.
doi: 10.1136/jnnp.66.3.370.

Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis

Affiliations

Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis

R Nabbout et al. J Neurol Neurosurg Psychiatry. 1999 Mar.

Abstract

Objectives: Intraventricular astrocytomas (subependymal giant cell astrocytomas) of tuberous sclerosis have a poor prognosis due to the obstruction of CSF flow. The aim of this study was to determine whether they could be differentiated during childhood and at an early preclinical stage, from subependymal nodules without any growing potential.

Methods: The first two MRIs of all children referred to this neuropaediatric centre between 1987 and 1996 were retrospectively blindly reviewed.

Results: Out of 60 patients, 24 disclosed subependymal nodules localised near the foramen of Monro, and eight of the 24 developed astrocytomas. Subependymal nodules were first detectable on MRI from 1 year of age in all cases and the first MRI evidence of growth occurred between 1 and 9 years (mean 4 years). At an early stage, subependymal nodules had different characteristics in patients who developed subependymal giant cell astrocytomas from those who did not. The nodules over 5 mm in diameter that were incompletely calcified and enhanced by gadolinium were at higher risk of growing, particularly in children with a familial history of tuberous sclerosis. To detect the subependymal giant cell astrocytomas earlier in tuberous sclerosis, it is advisible to systematically perform an MRI examination before 2 years of age and to repeat it every year if the patient has risk factors for developing astrocytomas.

PubMed Disclaimer

Comment in

References

    1. J Neurosurg. 1967 Feb;26(2):191-202 - PubMed
    1. Cancer Lett. 1996 Aug 23;106(1):75-82 - PubMed
    1. Surg Neurol. 1977 Aug;8(2):99-101 - PubMed
    1. Neurochirurgie. 1978;24(2):113-6 - PubMed
    1. Neurosurgery. 1979 May;4(5):410-7 - PubMed